hims semaglutide shortage Wegovy maker ends partnership with & Hers Wegovy maker sues Hims &

GLP-1 drugs were originally developed decades ago as diabetes treatments that alter the hormonal makeup of the brain and gut reducing hunger and slowing digestion

Recommendations outlined included: Screening for eating disorders before initiating GLP-1 medications Discussing risks related to weight suppression and discontinuation Monitoring medical, nutritional, and psychological status closely Collaborating across disciplines Approaching concerns with curiosity rather than judgment Ethical care requires attention not only to what medications can do, but also to whom they may harm

Casu et al

Lactation Risk Summary There are no data on the presence of fremanezumab-vfrm in human milk, the effects on the breastfed infant, or the effects on milk production

Vial Size & Duration Standard vial is 5 ml at 10 mg/ml = 50 mg total